Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. (Q51021030)
Jump to navigation
Jump to search
scientific article published on 13 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. |
scientific article published on 13 July 2011 |
Statements
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses (English)
F Grimaldi
G Scarpelli
V Ramundo
R Severino
M C Bellucci
G Lombardi
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference